FDA Increases OTC Monograph User Fees by 19 Percent for Fiscal 2022 Post author:PacConAdmin Post published:March 14, 2022 Post category:Drug Industry Daily The FDA has released its over-the-counter (OTC) monograph drug user fees for fiscal 2022. Source: Drug Industry Daily You Might Also Like Judge Approves Viatris Settlement of EpiPen Lawsuit for $264 Million July 13, 2022 FDA Approves Monthly Buprenorphine MAT for Opioid Use Disorder December 1, 2017 FDA Publishes List of Products Compounded by Outsourcing Facilities September 27, 2017